Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 4 (2008), Issue 5 (May)

1. Selective thyromimetics for atherosclerosis and dyslipidaemia: another old target making progress.
   Expert Opin Investig Drugs, 17(5): 615-8. [Abstract] [Full-text]
2. Ecotoxicological applications and significance of the comet assay.
   Mutagenesis, 23(3): 207-21. [Abstract] [Full-text]
3. Is personalized medicine finally arriving?
   Nat Biotechnol, 26(5): 509-17. [Abstract] [Full-text]
4. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.
   Nat Biotechnol, 26(5): 561-9. [Abstract] [Full-text]
5. The impact of target site accessibility on the design of effective siRNAs.
   Nat Biotechnol, 26(5): 578-83. [Abstract] [Full-text]
6. Expression and purification of human vascular-endothelial-growth-factor-receptor-2 tyrosine kinase in Streptomyces for inhibitor screening.
   Biotechnol Appl Biochem, 50: 113-9. [Abstract] [Full-text]
7. Four-alpha-helix bundle with designed anesthetic binding pockets. Part I: structural and dynamical analyses.
   Biophys J, 94(11): 4454-63. [Abstract] [Full-text]
8. Four-alpha-helix bundle with designed anesthetic binding pockets. Part II: halothane effects on structure and dynamics.
   Biophys J, 94(11): 4464-72. [Abstract] [Full-text]
9. Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs.
   Fundam Clin Pharmacol, 22(3): 241-6. [Abstract] [Full-text]
10. Clinical pharmacology: opportunities for educating new practitioners--an Australian perspective.
    Clin Pharmacol Ther, 83(6): 921-4. [Abstract] [Full-text]
11. IDMap: facilitating the detection of potential leads with therapeutic targets.
    Bioinformatics, 24(11): 1413-5. [Abstract] [Full-text]
12. Synthesis and bioassay of improved mosquito repellents predicted from chemical structure.
    Proc Natl Acad Sci U S A, 105(21): 7359-64. [Abstract] [Full-text]
13. Drug development of MET inhibitors: targeting oncogene addiction and expedience.
    Nat Rev Drug Discov, 7(6): 504-16. [Abstract] [Full-text]
14. Form to function: current and future roles for atherosclerosis imaging in drug development.
    Nat Rev Drug Discov, 7(6): 517-29. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.